Results 1 to 10 of about 29,753 (220)

Antepartum and Postpartum Thromboprophylaxis Preferences: Insights From a Single‐Center Survey [PDF]

Health Science Reports
Background Venous thromboembolism (VTE) is a significant contributor to maternal morbidity and mortality worldwide. Thromboprophylaxis guidelines are critical for VTE prevention, yet the optimal implementation of risk‐appropriate thromboprophylaxis ...
Zwidorulwa Rabali, Haroun A. Rhemtula, Elise Schapkaitz   +2 more
doaj   +2 more sources

Study protocol for the DISTINCT trial: inDividual, targeted thrombosIS prophylaxis versus the standard ‘one-size-fits-all’ approach in patients undergoing Total hIp or total kNee replaCemenT – a national, multicentre, randomised, multiarm, open-label trial [PDF]

BMJ Open
Introduction Patients undergoing total hip arthroplasty (THA) and total knee arthroplasty (TKA) are considered to have a symptomatic venous thromboembolism (VTE) risk of 1.0%–1.5% despite thromboprophylaxis.
Rob G H H Nelissen, Rolf H H Groenwold, Suzanne C Cannegieter, Menno V Huisman, Frederikus A Klok, Wilbert B van den Hout, Leti van Bodegom-Vos, Banne Nemeth, Nienke van Rein, Ruben Y Kok, Harmen B Ettema, Merel van Veen, Stephan B W Vehmeijer, Jan Joost I Wiegerinck   +13 more
doaj   +2 more sources

Effectiveness and Safety of Long-Term Venous Thromboembolism Prophylaxis After Colorectal Cancer Surgery: A Retrospective Study [PDF]

Drugs - Real World Outcomes
Background The optimal duration for thromboprophylaxis after colorectal cancer surgery remains uncertain. We sought to compare the effectiveness and safety of long-term thromboprophylaxis to that of short-term thromboprophylaxis in preventing venous ...
Ying Zhang, Xiaozhu Zhou, Yi Wu, Shicai Chen, Xiangli Cui, Ying Zhao   +5 more
doaj   +2 more sources

STAMP: surgical thromboprophylaxis adherence management programme [PDF]

BMJ Open Quality
Introduction Venous thromboembolism is the main cause of preventable in-hospital morbidity and mortality. Despite the recommendations available in the clinical practice guideline, there is low adherence to correct thromboprophylaxis.
Natalia Quintana-Montejo, Paulo Andres Cabrera Rivera, Stefany de Jesús Ríos Acuña, Danna Lesley Cruz Reyes   +3 more
doaj   +2 more sources

Underuse of medical thromboprophylaxis in mobile elderly inpatients: The SWITCO65+ cohort

Research and Practice in Thrombosis and Haemostasis, 2021
Background Hospital‐associated venous thromboembolism (HA‐VTE) can be prevented by pharmacologic thromboprophylaxis. Thrombotic risk assessment models (RAMs) are essential tools to improve inadequately prescribed thromboprophylaxis. Among cases of HA‐VTE,
Marc Blondon, Andreas Limacher, Marc Righini, Drahomir Aujesky, Marie Méan   +4 more
doaj   +1 more source

Modern thromboprophylaxis protocol based on guidelines applied in a respiratory intensive care unit: a single-center prospective cohort study

Thrombosis Journal, 2022
Background Critically ill patients in intensive care units (ICUs) are at high risk of venous thromboembolism (VTE). This study aimed to explore the prophylaxis effect under a guideline-based thromboprophylaxis protocol among critically ill patients in a ...
Xiao Tang, Wen-Rui Lyu, Yu Jin, Rui Wang, Xu-Yan Li, Ying Li, Chun-Yan Zhang, Wei Zhao, Zhao-Hui Tong, Bing Sun   +9 more
doaj   +1 more source

Unmet definitions in thromboprophylaxis for hospitalized medical patients: An appraisal for the need of recommendation

Research and Practice in Thrombosis and Haemostasis, 2022
Up to about 60% of venous thromboembolic events in a community are associated with hospitalization, and most can be prevented by appropriate thromboprophylaxis.
Bruno Ávila Ferreira, Marcos deBastos, Suely Meireles Rezende   +2 more
doaj   +1 more source

Thromboprophylaxis in primary shoulder arthroplasty does not seem to prevent death: a report from the Norwegian Arthroplasty Register 2005–2018

Acta Orthopaedica, 2021
Background and purpose — There is still no consensus on whether to use thromboprophylaxis as a standard treatment in shoulder replacement surgery. We investigated the use of thromboprophylaxis reported to the Norwegian Arthroplasty Register (NAR).
Randi M Hole, Anne Marie Fenstad, Jan-Erik Gjertsen, Stein A Lie, Ove Furnes   +4 more
doaj   +1 more source

Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN)

Orphanet Journal of Rare Diseases, 2022
Background Cushing’s syndrome (CS) is associated with an hypercoagulable state and an increased risk of venous thromboembolism (VTE). Evidence-based guidelines on thromboprophylaxis strategies in patients with CS are currently lacking.
F. M. van Haalen, M. Kaya, I. C. M. Pelsma, O. M. Dekkers, N. R. Biermasz, S. C. Cannegieter, M. V. Huisman, B. J. M. van Vlijmen, R. A. Feelders, F. A. Klok, A. M. Pereira, Endo-ERN Cushing and Thrombosis study group   +11 more
doaj   +1 more source

Preferences and Practices of Brazilian Orthopedists for Thromboprophylaxis Techniques in Total Knee Arthroplasty: Survey Among Members of the Brazilian Society of Knee Surgery (SBCJ) [PDF]

Revista Brasileira de Ortopedia, 2022
Objective The present study describes the preferences and current practices of a sample of knee surgeons in Brazil regarding thromboprophylaxis in total knee arthroplasty (TKA).
João Alberto Ramos Maradei-Pereira, Mateus Costa Barbosa, Derek Frederick Silva Newbery, Marcelo Rodrigues Torres, André Kuhn, Marco Kawamura Demange   +5 more
doaj   +1 more source